The Role of Inflammation in Brain and Cognitive Function in Mental Disorders
Latest Information Update: 14 Mar 2024
At a glance
- Drugs Natalizumab (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Acronyms IRIS
Most Recent Events
- 07 Mar 2024 Status changed from recruiting to completed.
- 23 Mar 2023 Planned End Date changed from 31 Mar 2023 to 30 Sep 2023.
- 23 Mar 2023 Planned primary completion date changed from 31 Mar 2023 to 30 Sep 2023.